Tomohisa Mori Selected Research

naloxonazine

10/2013	Mechanisms that underlie μ-opioid receptor agonist-induced constipation: differential involvement of μ-opioid receptor sites and responsible regions.
9/2013	Involvement of supraspinal and peripheral naloxonazine-insensitive opioid receptor sites in the expression of μ-opioid receptor agonist-induced physical dependence.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tomohisa Mori Research Topics

Disease

12	Pain (Aches) 01/2021 - 09/2009
7	Neuralgia (Stump Neuralgia) 07/2022 - 01/2014
6	Substance-Related Disorders (Drug Abuse) 01/2022 - 12/2004
4	Schizophrenia (Dementia Praecox) 01/2022 - 02/2012
4	Hyperalgesia 01/2022 - 01/2014
4	Body Weight (Weight, Body) 10/2014 - 08/2006
3	Hallucinations (Hallucination) 01/2022 - 01/2012
2	Neoplasms (Cancer) 01/2022 - 09/2009
2	Rupture 01/2018 - 07/2007
2	Constipation 01/2016 - 10/2013
2	Narcolepsy 01/2016 - 03/2010
2	Bone Neoplasms (Bone Cancer) 04/2015 - 01/2014
2	Substance Withdrawal Syndrome (Withdrawal Symptoms) 10/2014 - 09/2013
2	Diarrhea 10/2014 - 09/2013
2	Acquired Immunodeficiency Syndrome (AIDS) 06/2013 - 12/2011
2	HIV Infections (HIV Infection) 07/2012 - 12/2011
1	Chronic Pain 01/2022
1	Postoperative Pain 01/2021
1	Breakthrough Pain 01/2021
1	Sleep Wake Disorders 01/2016
1	Psychotic Disorders (Schizoaffective Disorder) 01/2016
1	Hypersensitivity (Allergy) 04/2015
1	Muscle Rigidity 01/2014
1	Parkinsonian Disorders (Parkinsonism) 06/2012
1	Parkinson Disease (Parkinson's Disease) 06/2012
1	Paralysis (Palsy) 05/2012
1	Postmortem Changes (Adipocere) 01/2011
1	Stroke (Strokes) 09/2009

Drug/Important Bio-Agent (IBA)

12	Morphine (MS Contin)FDA LinkGeneric 07/2022 - 07/2007
11	Opioid Receptors (Opioid Receptor)IBA 07/2022 - 11/2012
5	Opioid Analgesics (Opioids)IBA 07/2022 - 12/2004
5	Dopamine (Intropin)FDA LinkGeneric 01/2022 - 06/2012
5	Oxycodone (Oxycontin)FDA LinkGeneric 04/2015 - 09/2013
4	Pharmaceutical PreparationsIBA 01/2018 - 07/2007
4	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2018 - 07/2007
4	Fentanyl (Sublimaze)FDA LinkGeneric 01/2017 - 09/2013
4	Naloxone (Narcan)FDA LinkGeneric 07/2015 - 12/2007
3	Narcotic Antagonists (Opioid Antagonists)IBA 07/2015 - 09/2013
3	FullerenesIBA 10/2014 - 08/2006
2	((3- methoxythiophen- 2- yl)methyl)((2- (9- (pyridin- 2- yl)- 6- oxaspiro(4.5)decan- 9- yl)ethyl))amineIBA 01/2021 - 01/2017
2	Messenger RNA (mRNA)IBA 01/2021 - 07/2015
2	Ketamine FDA LinkGeneric 01/2018 - 01/2012
2	Illicit Drugs (Recreational Drugs)IBA 01/2018 - 01/2012
2	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 01/2018 - 01/2012
2	Phencyclidine (Angel Dust)IBA 01/2018 - 01/2012
2	Dopamine Receptors (Dopamine Receptor)IBA 01/2016 - 01/2007
2	OrexinsIBA 01/2016 - 03/2010
2	Pentazocine (Talwin)FDA LinkGeneric 07/2015 - 03/2015
2	LigandsIBA 03/2015 - 06/2012
2	Sigma-1 ReceptorIBA 03/2015 - 09/2009
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2014 - 01/2014
2	naloxonazineIBA 10/2013 - 09/2013
2	N-methylnaloxoneIBA 10/2013 - 09/2013
2	Cocaine (Cocaine HCl)IBA 07/2012 - 12/2011
1	G Protein-Coupled Inwardly-Rectifying Potassium ChannelsIBA 07/2022
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 07/2022
1	QuinpiroleIBA 01/2022
1	GSK-J4IBA 01/2021
1	antineoplaston A10 (A 10)IBA 01/2021
1	Histones (Histone)IBA 01/2021
1	AnnexinsIBA 01/2021
1	GTP-Binding Proteins (G-Protein)IBA 01/2021
1	Cornified Envelope Proline-Rich ProteinsIBA 01/2021
1	CannabinoidsIBA 01/2018
1	PLIalphaIBA 01/2018
1	MicroRNAs (MicroRNA)IBA 01/2016
1	8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)IBA 01/2016
1	Therapeutic UsesIBA 01/2016
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2016
1	5-HT1A Serotonin ReceptorIBA 01/2016
1	Formaldehyde (Formol)FDA Link 07/2015
1	naltrindoleIBA 07/2015
1	pre-prodynorphinIBA 07/2015
1	Ondansetron (Zofran)FDA LinkGeneric 10/2014
1	Olanzapine (Zyprexa)FDA Link 10/2014
1	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 10/2014
1	Atropine FDA LinkGeneric 10/2014
1	Free Radical ScavengersIBA 10/2014
1	RitanserinIBA 10/2014
1	MuscarineIBA 10/2014
1	Zolpidem (Ambien)FDA LinkGeneric 09/2014
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2014
1	tertiapinIBA 01/2014
1	Hypnotics and Sedatives (Sedatives)IBA 06/2013
1	BenzodiazepinesIBA 06/2013
1	Anti-Anxiety Agents (Anxiolytics)IBA 06/2013
1	Dronabinol (THC)FDA LinkGeneric 11/2012
1	Cannabinoid Receptor AgonistsIBA 11/2012
1	Antipsychotic Agents (Antipsychotics)IBA 02/2012
1	Lysergic Acid Diethylamide (LSD)IBA 01/2012
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 12/2011
1	Human Immunodeficiency Virus ProteinsIBA 12/2011
1	5,5- dimethyl- 5- hydroperoxy- 1- pyrrolidinyloxyIBA 01/2011
1	Ataxin-3IBA 03/2010

Therapy/Procedure

5	Ligation 07/2022 - 01/2016
1	Transplantation 01/2022
1	Electrocoagulation (Electrocautery) 01/2021
1	Therapeutics 07/2012
1	Laryngoplasty 05/2012
1	Anesthesia 05/2012